Shares in Intersect ENT (NSDQ:XENT) fell today after the medical device maker missed sales expectations on Wall Street with its second-quarter financial results. The Menlo Park, Calif.-based company posted a net loss of -$4.2 million on sales of $26.3 million for the 3 months ended June 30, for sales growth of 9.7% compared with the same […]
Aerie expands drug-delivery tech deal with DSM Biomedical
Aerie Pharmaceuticals (NSDQ:AERI) said today that it expanded its drug-delivery R&D deal with DSM Biomedical. The two companies first joined forces in July last year to evaluate the sustained delivery of certain Aerie drugs using DSM’s polymer technology. Initially, the group was focused on developing drug-delivery tech for people with wet age-related macular degeneration and diabetic […]
Valeritas launches V-Go insulin delivery device in New Zealand
Valeritas (NSDQ:VLRX) said today that its V-Go wearable insulin delivery device is now available in New Zealand thanks to an exclusive distribution deal with NZMS Diabetes. According to the terms of the agreement, Valeritas will be responsible for product development, regulatory approval, manufacturing and quality management while NZMS Diabetes will take over the sales, marketing, customer […]
Medtronic wins FDA nod to deliver PAH therapy with implantable pump
Medtronic (NYSE:MDT) said today that it won FDA approval for its implantable drug-delivery system designed to administer United Therapeutics‘ (NSDQ:UTHR) pulmonary arterial hypertension drug, Remodulin. United Therapeutics is slated to take the lead on commercial promotion of the drug-device system, with support from Medtronic. The system includes Medtronic’s SynchroMed II implantable pump and a new intravascular […]
Tandem posts mixed Q2 results
Shares in Tandem Diabetes Care (NSDQ:TNDM) fell this week after the insulin pump maker topped sales expectations but missed earnings estimates on Wall Street with its second-quarter financial results. The San Diego, Calif.-based company posted a net loss of -$59.4 million on sales of $34.1 million for the 3 months ended June 30, for sales growth of […]
SFC Fluidics lands JDRF support for interoperable insulin patch pump
SFC Fluidics said today that it inked a deal with JDRF to support the development of an insulin patch pump with open-protocol communication features. SFC Fluidics plans to use the two-year funding deal from JDRF to speed up the development of a patch pump that securely connects with other devices, like a continuous glucose monitor […]
The future of Abbott’s electrophysiology business
At DeviceTalks Minnesota 2018, medtech veteran Michael Pederson provided an inside look at the Abbott-St. Jude Medical merger and what’s ahead for Abbott’s cardiovascular technologies. Pederson tracked his career from a formative stint at HP to his current role as SVP of cardiac arrhythmias and heart failure at Abbott (NYSE:ABT). Get the full story at our sister […]
Nanobiotix inks $47m financing to support nanomedicine development
Nanobiotix (PAR:NANO.PA) inked a non-dilutive financial deal with the European Investment Bank last week to support the development of its nanoparticle-based cancer therapies. The Paris, France-based company said it landed a five-year loan to borrow up to €40 million ($46.7 million) contingent upon a set of performance milestones. Nanobiotix plans to use the funds to bring its NBTXR3 […]
Abbott wins FDA nod for 14-day FreeStyle Libre glucose sensor
Abbott (NYSE:ABT) said today that the FDA approved its 14-day FreeStyle Libre flash glucose monitor, making the device the longest lasting self-applied glucose sensor on the market. The company’s FreeStyle Libre system, initially approved to last 10 days, is designed to eliminate the need for fingersticks. Users can test their blood sugar with the continuous glucose […]
Novo Nordisk exec: In the digital age, it’s not enough to have a better molecule
Much of Dr. Todd Hobbs’ life has centered around diabetes – he was diagnosed with Type I diabetes roughly 30 years ago and now he is the father of a child with diabetes. At his Kentucky-based primary care practice, he took on diabetic patients and helped manage their care. And when he made the jump […]
